Alibaz-Oner, F. Et Al. 2018. IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY. Congress of the European-League-Against-Rheumatism (EULAR) , (Amsterdam, Netherlands), 1118-1119.

Alibaz-Oner, F., Balci, M. A., Pamuk, O. N., Zengin, O., Tasci, M., Dogru, A., ... Bayindir, O.(2018). IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY . Congress of the European-League-Against-Rheumatism (EULAR) (pp.1118-1119). Amsterdam, Netherlands

Alibaz-Oner, F. Et Al. "IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY," Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 2018

Alibaz-Oner, F. Et Al. "IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.1118-1119, 2018

Alibaz-Oner, F. Et Al. (2018) . "IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.1118-1119.

@conferencepaper{conferencepaper, author={F. Alibaz-Oner Et Al. }, title={IS RELAPSE RATE OF GIANT CELL ARTERITIS IN REAL-LIFE EXPERIENCE LOWER THAN IN THE CONTROLLED TRIALS? RESULTS OF A RETROSPECTIVE, MULTI-CENTRE COHORT STUDY}, congress name={Congress of the European-League-Against-Rheumatism (EULAR)}, city={Amsterdam}, country={Netherlands}, year={2018}, pages={1118-1119} }